V-158866

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameV-158866
Drug Alias NameV-158866
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnandamide amidohydrolase inhibitors
TargetsAnandamide amidohydrolase
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVernalis Plc
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A